Schweiger Dermatology Group

Schweiger Dermatology Group

Schweiger Dermatology Group was founded by Dr. Eric Schweiger in New York City, growing from a solo dermatology practice into a multi-site healthcare platform that now spans New York, New Jersey, Pennsylvania, and Connecticut. The wealth originates from clinical dermatology services, cosmetic procedures, and the real estate associated with an expanding network of medical offices. The group operates as a physician-led, private-equity-backed healthcare roll-up, with LLR Partners investing in 2017 to accelerate acquisitions and de novo clinic openings. The investment strategy is concentrated in healthcare services and the commercial real estate that houses the clinics — many properties are owned or controlled by related entities. Known holdings include the clinical operations themselves, the real estate portfolio of medical office buildings across the Northeast, and minority stakes in adjacent dermatopathology labs and pharmacy services. The geographic footprint is concentrated in the New York metro area, with additional density in Philadelphia and New Jersey. The firm has scaled to over 90 locations with more than 300 healthcare providers, making it among the largest dermatology groups in the United States. In September 2023, the group continued its expansion with new clinic openings in Connecticut (per public record, September 2023). Adjacent to the clinical business, the Schweiger family has been cited in real estate transactions involving medical office properties that house the clinics, suggesting an integrated operating-company and real-asset approach rather than a traditional family office structure. The structural differentiator is that Schweiger operates less like a conventional family office and more like an owner-operator platform: the wealth is embedded in an actively managed healthcare enterprise, with the real estate and clinical operations held in a unified structure that generates both operating income and property appreciation. This blurs the line between family office investing and hands-on business management, making the group's posture closer to that of a vertically integrated healthcare holding company.